Smith & Nephew PLC (NYSE:SNN) shares gapped down prior to trading on Monday . The stock had previously closed at $32.04, but opened at $32.70. Smith & Nephew PLC shares last traded at $33.47, with a volume of 333,300 shares traded.

A number of research firms have weighed in on SNN. Jefferies Group upgraded shares of Smith & Nephew PLC from a “hold” rating to a “buy” rating in a research note on Monday, May 9th. Zacks Investment Research lowered shares of Smith & Nephew PLC from a “buy” rating to a “hold” rating in a research note on Wednesday, May 11th. Barclays PLC lowered shares of Smith & Nephew PLC from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, August 10th. Finally, Beaufort Securities restated a “hold” rating on shares of Smith & Nephew PLC in a research note on Wednesday, August 10th. One analyst has rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company’s stock. Smith & Nephew PLC presently has a consensus rating of “Hold” and a consensus target price of $37.00.

The stock has a 50-day moving average price of $33.61 and a 200-day moving average price of $33.57. The firm has a market cap of $14.96 billion and a P/E ratio of 42.15.

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.